NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT2080221268

Registered date:18/10/2010

Basic Information

Recruitment status
Health condition(s) or Problem(s) studiedUncontrollable cancer pain
Date of first enrollment18/10/2010
Target sample size
Countries of recruitment
Study typeInterventional
Intervention(s)investigational material(s) Generic name etc : TK-642 INN of investigational material : Methadone Hydrochloride Therapeutic category code : 821 Synthetic narcotics Dosage and Administration for Investigational material : Oral

Outcome(s)

Primary OutcomeEfficacy and Safety
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum>= 20age old
Age maximum<= 74age old
GenderBoth
Include criteria1)Japanese cancer patients who can be hospitalized for clinical trial 2)Patients who are 20-74 years old at the time of informed consent 3)Patients who have been received cancer pain therapy with opioid for over 1 week etc.
Exclude criteria1)Patients who have any complications or history of cardiac conduction disturbance 2)Patients who have any complications or history of abnormality of respiratory function 3)Patients with any organic encephalopathies etc.

Related Information

Contact

Public contact
Name
Address rinsho@teiyaku.co.jp
Telephone
E-mail
Affiliation TEIKOKU SEIYAKU CO., LTD.
Scientific contact
Name
Address
Telephone
E-mail
Affiliation